+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)


After an overwhelming response on our Annual Biomarker Conference, Markets and Markets Conferences is pleased to announce The 2nd Annual Biomarker Conference which will take place on the 6th and 7th of February 2017, in San Diego-CA, USA.

The recent success of companion diagnostics along with the increasing regulatory pressure for better identification of the target population has created an extraordinary spur for drug discovery companies to invest in novel strategies for biomarker discovery. Also, the confluence of immunology and oncology tributaries has triggered a biomarker turbulence that is novel to the cancer community.

The pursuit to drive precision medicine and the quest to refine a biomarker model for immuno-oncology drug development, The 2nd Annual Biomarker Conference aims to gather experts from pharma, bio-pharma companies and research institutes to discuss current challenges and opportunities in biomarker discovery, CDx, NGS, regulatory and reimbursement issues and novel technologies.

Post Show Report 2016
Click here to view post show report of The Biomarker Conference 2016

This event is co-located with our 2nd Annual NGS Data Analysis and Informatics Conference and 2nd Annual Genome Editing & Engineering Conference


conference Registration Form



Academic Delegate$399
Industry Delegate $499
Solution Provider Delegate$999
University & Research Institutes (Early Bird) - 30th June 2017$299
Industry Delegate (Early Bird) - 31st October 2017$399


Key Highlights:
  • Translational Medicine and biomarkers
  • NGS and Circulating biomarkers
  • Biomarkers in Immuno-Oncology
  • Liquid Biopsies
  • Complementary diagnostics v/s Companion diagnostics
  • Adaptive trial designs
  • Regulatory and Reimbursement Issues
  • Patient stratification
  • Novel technologies in biomarkers
  • Pre-clinical biomarker to clinical biomarkers

Who Should Attend ?

Who should attend?

CSOs, VPs, Directors, Heads, Managers, Laboratory Heads, Senior Scientists, Principal Scientist, Researchers, Professors from Pharma, Bio-Pharma and research Institutes working in :-

  • Biomarker
  • Clinical Biomarker
  • Biomarker Sciences
  • Oncology Biomarker Development
  • Biomarker Discovery
  • Biomarker Operations
  • Translational research/Sciences
  • Companion Diagnostics
  • Precision medicine
  • Personalised medicine
  • Biomarker research
  • Biological Sciences
  • Immuno-Oncology
  • Immunology Biomarkers

Why attend:
  • 30+ experts from academia and industry presenting their current work in Biomarkers
  • Latest updates on regulatory guidelines and approvals
  • Case studies from experts who have successfully created and developed a biomarker
  • Facilitated networking sessions to ensure quality interactions
  • One on one query handling by biomarker experts
  • Opportunity to develop long-lasting business relationships and networking opportunities with senior peers

Advisory Panel

  • Darrell Borger
    Director, Biomarker Laboratory,
    Mass General Hospital, Massachusetts

  • Thomas Schlange
    Senior Biomarker Scientist, 
    Global Biomarker Research
    , Bayer Healthcare, UK

  • Dave Hoon
    Director Molecular Oncology,
    John Wayne Cancer Institute, California

  • Jianda Yuan
    Director Translational Immuno-Oncology Research,
    Early Clinical Oncology, 
    Merck, New York

  • Rajiv Raja
    Director R & D Translational Medicine and Pharmacogenomics, 
    MedImmune Astrazeneca, Maryland


  • Gary Kelloff

    Special Advisor, NIH/NCI, Maryland
  • Ann Kapoun

    VP Translational Medicine, Onco Med Pharmaceuticals, California
  • Dave Hoon

    Director Molecular Oncology, John Wayne Cancer Institute, California
  • Abdel Halim

    VP Translational Medicine, Biomarkers & Diagnostics, Celldex Therapeutics, New Jersey
  • Janku Philip

    Associate Professor, MD Anderson, Texas
  • Deepak Khatry

    Science Associate Director, Statistical Sciences, MedImmune, Maryland
  • Razelle Kurzrock

    Chief, Division of Hematology and Oncology, UCSD School of Medicine, Director, Center for Personalized Cancer Therapy, Director, Clinical Trials Office, UCSD Moores Cancer Center, California
  • Saurabh Gupta

    Associate Director Translational Medicine Group, Takeda Oncology, Massachusetts
  • Dr. J. Carl Barrett

    Vice President, Translational Science in Oncology, AstraZeneca
  • Dr. Sriram Sathyanarayanan

    Director, Translational Sciences, Jounce Therapeutics Inc.
  • Dr. Mark E. Curran

    VP, Systems Pharmacology and Biomarkers Immunology Therapeutic Area Janssen Research & Development, LLC
  • Dr. Sandip Patel

    Assistant Professor, Cancer Immunotherapy Program, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center
  • Anneli Andersson

    Scientific Project Manager NEBION AG, Switzerland
  • Jon Armstrong

    CSO, Cofactor Genomics, San Diego
  • Janusz Dutkowski

    CEO, Data4Cure, Inc., California
  • Kamala K Maddali

    VP, Biopharm Market Development, Collaborations and Companion Diagnostics Cancer Genetics, Inc., New Jersey
  • Jeffrey Miner

    Executive Director AstraZeneca (Ardea Biosciences), California
  • Matt Johnson

    Chief Technology Officer Avacta Life Sciences, United Kingdom
  • Dr. TuDung Nguyen

    Medical Director, CGI-West Cancer Genetics Inc., California
  • Rob Fannon

    VP, Biopharm Solutions, Cancer Genetics Inc., North Carolina
  • Alexandre Akoulitchev

    CSO, Oxford BioDynamics Plc, United Kingdom
  • Niki Heinz

    Business Development Director, Asterand Bioscience, United States/United Kingdom
  • Bob Terbrueggen

    Founder & CEO, DxTerity Diagnostics


Platinum Sponsors

Cancer GeneticsCancer Genetics

Cancer Genetics, Inc. is a leader in enabling precision medicine from bench-to-bedside. In addition to its clinical diagnostics business, Cancer Genetics actively supports biopharma companies with genomic-based, comprehensive oncology biomarker testing and companion diagnostic strategies through its state-of-the-art CLIA-certified and CAP-accredited reference labs in New Jersey and California.

d Sponsors


DxTerity is an ISO 13485 certified and 21 CFR 820 compliant molecular diagnostic development company and CAP CLIA laboratory based in Los Angeles.  We develop simple, fast and affordable genomic tests for disease diagnosis and therapy monitoring.  DxTerity Diagnostics is transforming genomic research with the introduction of Direct-To-Patient (D2P) Genomic Studies that enable more frequent transcriptomic monitoring via patient-collected fingerstick blood samples. Our unique “From Home” genomics platform provides both translational and clinical researchers with broader access to biomarker datasets from a minimal amount of genomic material. This allows for easy longitudinal monitoring of disease progression and drug activity.


Silver Sponsors

Avacta Avacta Life Sciences

“Affimer® reagents are affinity proteins, based on a small protein scaffold engineered to bind with high specificity and affinity to a range of targets. With a 7 week custom service and an online catalogue, they are used for various applications in diagnostics, drug/biomarker discovery, biotech R&D and as therapeutic agents.”



Cofactor - Sponsor for 2nd Annual Biomarker Conference - San DiegoCofactor Genomics

Cofactor is leading the charge on moving RNA-seq out of discovery and into diagnostics. Working with the largest life-science and pharmaceutical companies in the world, we’ve developed streamlined and scalable protocols to interrogate RNA. By standardizing RNA-seq products, we deliver fully-analyzed results in 3 weeks, with trustworthy data and support.  Our team is available as an extension of your discovery/pre-clinical research group, and our CAP/CLIA accredited lab is well-suited for developing customized companion assays.

Nebion - Sponsor for 2nd Annual Biomarker Conference Nebion AG

Nebion AG is a Swiss company founded by an interdisciplinary group of scientists. The goal of Nebion is to support discovery, translational biology and personalized medicine research in academia and industry by curating, integrating and mining molecular data on a very large scale. Nebion currently commercializes Genevestigator®, the premier gene expression search engine used by over 56’000 researchers world-wide.

Asterand Bioscience
Asterand Bioscience

Asterand Bioscience 
is the leading global provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification of drug targets and enhance the selection of drug candidates with increased likelihood of clinical success.

Oxford BioDynamics

Oxford BioDynamics

Oxford BioDynamics Plc is a biotechnology company offering a proprietary biomarker discovery platform, EpiSwitch™. Our award-winning technology based on Chromosomal Conformation Signatures (CCSs) offers biomarkers to treat the right patients with the right drug at the right dose at the right time.  We have validated the potential of EpiSwitch™ in a wide range of conditions, such as immunotherapies. Our proprietary technology will enable pharmaceutical companies to accelerate and improve the rate of drug development.



Data4Cure’s CURIE™ turns vast amounts of genomic and clinical data into a continuously updated biomedical knowledge graph. Its patent-pending technology discovers and catalogs recurring components and pathways responsible for disease development, progression and treatment response,  significantly increasing statistical power and facilitating continuous translation of data to knowledge.


Sponsorship Opportunity


MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

 For sponsorship opportunities please contact Ajay Nimbalkar at ajay.nimbalkar@mnmconferences.com


Poster Presentations:

All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & Academia.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Ajay Nimbalkar
Email: ajay.nimbalkar@mnmconferences.com
Tel:+91 20 6708 0299

Posters Submission Form



California LifeSciencesCalifornia Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization.

AZBioAZBio (Arizona Bioindustry Association)
AZBio (Arizona Bioindustry Association) is committed to making LIFE better for people and to supporting the collaborative efforts of  its members in growing Arizona’s bioscience industry. Over 1,400 life science companies call Arizona “home” including: Arizona Alzheimer’s Consortium, Arizona State University (home of the Biodesign institute and the National Biomarker Development Alliance), Barrow Neurological Institute at St. Joseph’s Hospital (Dignity Health), Banner MD Anderson, Banner Health Research Institutes, Cancer Treatment Centers of America, Mayo Clinic, Translational Genomic Research Institute (TGen), Virginia G. Piper Cancer Center(HonorHealth), and The University of Arizona.  Learn more at www.AZBio.org

Colorado BSAColorado BioScience Association
Colorado BioScience Association champions life science. The not-for-profit organization represents more than 350 member organizations and serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA grows the bioscience workforce and leads business expansion policies to advance the industry in our state.


BioUtah is an independent, non-profit 501(c)(6) trade association serving Utah's life science industry. Our primary members include organizations focused on research and development, manufacturing and commercialization or provide supportive services to life science technologies and treatments.

Utah’s life science industry consists of a diverse spectrum with strengths in medical device manufacturing and services, research and testing, biotechnology, pharmaceuticals and healthcare IT amongst others; and is a key driver of Utah’s economy.

Georgio BioGeorgia Bio
Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

DNA Digest

DNAdigest is a non-profit organisation founded in 2013 in Cambridge, UK. The objectives of DNAdigest are to educate, facilitate, and engage on issues regarding access to genomic data for research. DNAdigest organises symposia, hackdays, issues a newsletter and publishes a blog(dnadigest.org/news)
DNAdigest is a community of individuals from diverse backgrounds who all want to see data used to its full potential for the benefit of patients. DNAdigest is part of the Global Alliance for Genomics and Health(https://genomicsandhealth.org)

RegMedNet is a free online information and networking hub covering all aspects of the multidisciplinary field of regenerative medicine. By allowing members to quickly access user-generated news, discussion and opinion from the fast-moving and diverse field, share their own content and insights, and access key journal articles, RegMedNet enables the knowledge sharing, connection and collaboration that will help this exciting field progress further and bring benefits to patients faster.

Northwest Association for Biomedical Research
Northwest Association for Biomedical Research (NWABR)
Northwest Association for Biomedical Research (NWABR) was founded in 1989 with a mission to promote the understanding of biomedical research and its ethical conduct.  NWABR is an independen
t membership based 501(c) 3 association representing the biomedical research community.  NWABR’s members represent leaders in the biomedical and biotechnology industry, universities and non-profit organizations.  We work with and for our members to strengthen public trust in research through education and dialogue. 
As a membership based organization NWABR encourages personal interactions between scientists, the public, students, and teachers, helping to demystify the scientific process.  As a connector between the academic and scientific communities and the public, NWABR accomplishes its mission by providing opportunities to engage people through various channels of communication, such as social media, electronic newsletters, events, networking sessions, student and teacher education programs, and by continuing best practices education for the biomedical research community.

Maine BioscienceThe Bioscience Association of Maine (BAM)
The Bioscience Association of Maine (BAM) is a trade organization which promotes the industry's steady growth, interprets its benefits to the public, and influences pertinent public policy.
 As the association for Maine’s life sciences community, BAM promotes cooperation between Maine’s bioscience-related businesses, supports the biotech industry in the state and beyond, develops business-to-business opportunities, and serves as a united industry voice to promote a science-friendly environment.



The 2nd Annual Biomarker Conference will be held at the San Diego Marriott La Jolla in USA.

San Diego Marriott La Jolla

4240 La Jolla Village Drive,
La Jolla, California - 92037

Hotel Booking Link

Our block of rooms at the congress rate has now been filled.  You can see a list of nearby hotels by clicking here.  (Please note that we do not authorise any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us.  If you are contacted by anyone other than me regarding your accommodation requirements for this event, please let us know immediately)

About the Hotel

Effortlessly stylish and filled with exceptional amenities, the San Diego Marriott La Jolla offers the perfect home base for your visit to the Golden Triangle. Hotel's central location provides hassle-free access to many of downtown La Jolla's most popular attractions, as well as to the University of California at San Diego. Pet-friendly rooms and suites include deluxe pillowtop beds, marble bathrooms and high-speed Wi-Fi; many also feature private balconies.

For further Information please contact:
Email: events@marketsandmarkets.com